Amarin Corporation plc (AMRN)
Nasdaq: AMRN · Pharmaceutical Preparations · Dublin 2 · filing with the SEC since 1998
Who owns Amarin Corporation plc
As filed with the SECHolders of 5% or more
1
Sarissa Capital Management LP holds 6.09% of Ordinary Shares, par value 50 pence per share, as its SCHEDULE 13D/A filed Aug 27, 2026 says.
Directors and officers
12
report now, of 36 people on the record since 2010. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Sarissa Capital Management LP
SCHEDULE 13D/A · filed Aug 27, 2026 · Ordinary Shares, par value 50 pence per share · 8.08% in Mar 25, 2025
What AMRN reports owning in othersstakes of 5% or more, and other ties
18 subsidiaries in 18 countries, from the list filed with the 10-K filed Mar 2, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2024 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.